{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T21:30:30Z","timestamp":1785533430260,"version":"3.56.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":6307,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1093\/annonc\/mdf268","type":"journal-article","created":{"date-parts":[[2002,11,7]],"date-time":"2002-11-07T02:18:26Z","timestamp":1036635506000},"page":"1665-1673","source":"Crossref","is-referenced-by-count":56,"title":["Induction chemotherapy with paclitaxel, cisplatin and5-fluorouracil for squamous cell carcinoma of the head and neck: long-term results of a phase II trial"],"prefix":"10.1016","volume":"13","author":[{"given":"R.","family":"Hitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Paz-Ares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Brand\u00e1riz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Mill\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Ortiz de Urbina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"\u00c1lvarez-Vicent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Cort\u00e9s-Funes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdf268_bb0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.49.1.8","article-title":"Cancer statistics. 1999","volume":"49","author":"Landis","year":"1999","journal-title":"CA Cancer J Clin"},{"key":"10.1093\/annonc\/mdf268_bb0015","series-title":"Holland\u2013Frei Cancer Medicine","first-page":"1173","article-title":"Head and neck neoplasms","author":"Clayman","year":"2000"},{"key":"10.1093\/annonc\/mdf268_bb0020","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJM199106133242402","article-title":"Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer","volume":"324","author":"The Department of Veterans Affairs Cancer Study Group","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdf268_bb0025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/jnci\/86.4.265","article-title":"Marchiori et al. A phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study of the Gruppo di Studio sui Tumori della Testa e del Collo","volume":"86","author":"Pacagnella","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdf268_bb0030","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/jnci\/88.9.583","article-title":"Five year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in the treatment of unresectable squamous cell carcinoma of the head and neck","volume":"88","author":"Merlano","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdf268_bb0035","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/jnci\/88.13.890","article-title":"Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer Phase III trial","volume":"88","author":"Lefebre","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdf268_bb0040","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/bjc.1995.17","article-title":"An overview of randomized trials of adjuvant chemotherapy in head and neck cancer","volume":"71","author":"Munro","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdf268_bb0045","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1200\/JCO.1996.14.3.838","article-title":"Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: a meta-analysis of prospective randomized trials","volume":"14","author":"El-Sayed","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf268_bb0050","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-4","article-title":"on behalf of the MACH-NC Collaborative Group. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data","volume":"355","author":"Pignon","year":"2000","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdf268_bb0055","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2270::AID-CNCR24>3.0.CO;2-Q","article-title":"Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group Trial (PA390)","volume":"82","author":"Forastiere","year":"1998","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdf268_bb0060","first-page":"41","article-title":"A phase II trial of paclitaxel in squamous cell carcinoma of the head and neck with correlative studies","volume":"22","author":"Smith","year":"1995","journal-title":"Semin Oncol"},{"key":"10.1093\/annonc\/mdf268_bb0065","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/0959-8049(96)00002-0","article-title":"Single agent paclitaxel in advanced squamous cell head and neck carcinoma","volume":"32","author":"Gebbia","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdf268_bb0070","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/oxfordjournals.annonc.a058908","article-title":"Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck","volume":"5","author":"Catimel","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdf268_bb0075","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1200\/JCO.1996.14.5.1672","article-title":"Docetaxel: an active drug against squamous cell carcinoma of the head and neck","volume":"14","author":"Dreyfuss","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf268_bb0080","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1023\/A:1008248627396","article-title":"Cisplatin\u2013paclitaxel weekly schedule in advanced solid tumors: a phase I study","volume":"8","author":"Frasci","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdf268_bb0085","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000227669","article-title":"Paclitaxel administered over 3h followed by cisplatin in patients with advanced head and neck squamous cell carcinoma: a clinical phase I study","volume":"54","author":"Schilling","year":"1997","journal-title":"Oncology"},{"key":"10.1093\/annonc\/mdf268_bb0090","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0959-8049(99)81107-1","article-title":"Phase II study of placitaxel and cisplatin in advanced and recurrent head and neck cancer","volume":"35","author":"Adamo","year":"1999","journal-title":"Eur J Cancer"},{"issue":"Suppl 5","key":"10.1093\/annonc\/mdf268_bb0095","first-page":"80","article-title":"A phase II study of weekly 1-hour paclitaxel (T) and 24-hour infusion with high-dose fluorouracil (5-FU) with leucovorin (LV) for advanced carcinoma of the head and neck","volume":"7","author":"Constela-Figueiras","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdf268_bb0100","first-page":"20","article-title":"Phase I\/II of paclitaxel\/cisplatin as first line therapy for locally advanced head and neck cancer","volume":"24","author":"Hitt","year":"1997","journal-title":"Semin Oncol"},{"key":"10.1093\/annonc\/mdf268_bb0105","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1200\/JCO.1997.15.5.2050","article-title":"Why has induction chemotherapy for advanced head and neck cancer become a United States Community standard of practice?","volume":"15","author":"Harari","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf268_bb0110","series-title":"American Joint Committee on Cancer. AJCC Cancer Staging Manual","year":"1997"},{"key":"10.1093\/annonc\/mdf268_bb0115","series-title":"WHO offset publication","article-title":"WHO Handbook for reporting results of cancer treatment","volume":"48","author":"World Health Organization","year":"1979"},{"key":"10.1093\/annonc\/mdf268_bb0120","series-title":"Statistical Methods in Medical Research","author":"Armitage","year":"1994"},{"key":"10.1093\/annonc\/mdf268_bb0125","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2307\/2531294","article-title":"Confidence limits for probability of response in multistage phase II clinical trials","volume":"41","author":"Atkinson","year":"1985","journal-title":"Biometrics"},{"key":"10.1093\/annonc\/mdf268_bb0130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc B"},{"key":"10.1093\/annonc\/mdf268_bb0135","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1200\/JCO.1998.16.4.1318","article-title":"Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study","volume":"16","author":"Wendt","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf268_bb0140","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1200\/JCO.1999.17.2.638","article-title":"Radiation therapy with concomitant hydroxyurea and fluorouracil in stage II and III head and neck cancer","volume":"17","author":"Haraf","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf268_bb0145","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/jnci\/84.11.877","article-title":"Favorable long-term survival following induction chemotherapy with PFL and concomitant chemoradiotherapy for locally advanced head and neck cancer","volume":"84","author":"Vokes","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdf268_bb0150","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1200\/JCO.1995.13.4.876","article-title":"Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: Impact on the natural history of the disease","volume":"13","author":"Vokes","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf268_bb0155","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1200\/JCO.2000.18.21.3665","article-title":"Physician compliance with warfarin prophylaxis for central venous catheters in patients with solid tumors","volume":"18","author":"Carr","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf268_bb0160","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1200\/JCO.1998.16.5.1826","article-title":"Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus","volume":"16","author":"Ilson","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf268_bb0165","first-page":"1723","article-title":"Phase I and pharmacological study of a 3-hour infusion of paclitaxel followed by cisplatinum and 5-fluorouracil in patients with advanced solid tumors","volume":"5","author":"Bhalla","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdf268_bb0170","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/(SICI)1097-0142(19990115)85:2<295::AID-CNCR5>3.0.CO;2-H","article-title":"Paclitaxel, cisplatin and 5-fluorouracil combination chemotherapy for the treatment of advanced gastric carcinoma","volume":"85","author":"Kim","year":"1999","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdf268_bb0175","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11<2364::AID-CNCR26>3.0.CO;2-3","article-title":"Paclitaxel, cisplatin and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck","volume":"86","author":"Hussain","year":"1999","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdf268_bb0180","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00001622-200005000-00007","article-title":"Integration of taxanes into primary chemotherapy for squamous cell carcinoma of the head and neck: promise fulfilled?","volume":"12","author":"Brockstein","year":"2000","journal-title":"Curr Opin Oncol"},{"key":"10.1093\/annonc\/mdf268_bb0185","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1200\/JCO.1998.16.4.1331","article-title":"Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase II trial","volume":"16","author":"Colevas","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf268_bb0190","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1200\/JCO.1999.17.11.3503","article-title":"A phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neck","volume":"17","author":"Colevas","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf268_bb0195","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1200\/JCO.2001.19.4.1096","article-title":"Multicenter phase I\u2013II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck","volume":"19","author":"Posner","year":"2000","journal-title":"J Clin Oncol"},{"issue":"Abstr 1534","key":"10.1093\/annonc\/mdf268_bb0200","first-page":"18","article-title":"Phase I\u2013II study with docetaxel (D), cisplatin (C), and 5-fluorouracil (5-FU) in patients (PTS) with locally advanced squamous cell carcinoma of the head and neck (SCCHN)","volume":"394a","author":"Schrijvers","year":"1999","journal-title":"Proc Am Soc Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419637622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419637622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/13\/10\/1665\/399565\/mdf268.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T04:49:12Z","timestamp":1733892552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419637622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["S0923753419637622"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdf268","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}